Emmvee Photovoltaic Power Ltd Q1 FY27 Earnings Call: Guides Rs. 2,400 Cr EBITDA Target, 6 GW TOPCon Expansion On Track

Emmvee Photovoltaic Power Ltd held its Q1 FY27 earnings call on July 15, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Record Production and Profitability Mark the Quarter

• Revenue from operations at Rs.1,555 Cr (+51% YoY), driven by record module production of 970 MW (+53% YoY) and cell production of 454 MW (+26% YoY).
• EBITDA came in at Rs.548.1 Cr (+56% YoY), with margin expanding to 35.2% from 32.84% in the prior comparable quarter, aided by operational efficiencies and product mix.
• PAT surged 103% YoY to Rs.380.3 Cr — finance costs dropped sharply to Rs.11.1 Cr from Rs.53.1 Cr in Q1 FY25-26, contributing significantly to the bottom-line outperformance.
• Order book strengthened to 9.9 GW (up from 9.4 GW at end-FY25-26), with fresh order inflows of ~1.5 GW during the quarter. Management noted ~7+ GW is executable over the next 18 months.
• Cell capacity utilization hit 83% in Q1 FY26-27 (vs 68% in Q1 FY25-26 and 79% in Q4 FY25-26), reflecting the benefits of the integrated manufacturing platform.

6 GW TOPCon Expansion on Track; Ingot-Wafer Plans Formalized

• The 6 GW integrated TOPCon cell and module facility is progressing on schedule — module line commissioning by December 2026 (Q3 FY26-27) and cell line by March 2027. Total project cost is ~Rs.5,500 Cr (hard costs Rs.4,600 Cr), with Rs.3,300 Cr of debt tied up at <8% cost.
• Post-expansion, total capacity will reach ~16.3 GW of modules and ~8.9 GW of cells by end of FY 2026-2027, cementing Emmvee's position among the largest domestic solar manufacturers.
• Management formalized a medium-term plan for backward integration into ingot & wafer — a 9 GW facility in two phases: 5 GW targeted in FY 2028-2029 and 4 GW in FY 2029-2030. Capex is expected to be funded largely from internal accruals, subject to ALMM List 3 clarity and market conditions.
• Wafer ingot commissioning is targeted by mid-calendar 2028; management stated that no board approval is required at this stage, and priority remains on the immediate cell and module expansion.
• The government is "reportedly clear on intentions to focus on bringing in ingot and wafer manufacturing" under the ALMM framework, which management cited as a supportive policy tailwind for the planned backward integration.

EBITDA Per Watt Disclosed Across Product Paths; Guidance Maintained

• Management guided module-level EBITDA at Rs.2-2.5 per unit for FY 2026-2027, supported by a targeted module capacity utilization of 50-60% for the year. No specific breakdown was given for blended DCR/non-DCR vs non-DCR only.
• Three distinct margin buckets were disclosed (period unspecified): non-DCR modules earn ~Rs.2-2.5/watt, standalone cells earn ~Rs.6.5/watt, and DCR modules earn ~Rs.8.5-9/watt. Margins for selling cells and modules separately are "pretty much similar" to integrated DCR modules.
• Absolute EBITDA target of Rs.2,400 Cr by end of FY 2026-2027 was reiterated, with management guiding strictly on absolute EBITDA rather than margin percentage.
• EBITDA margin improved to 35.2% in Q1 FY26-27 (from 32.84% in a prior comparable quarter), driven by operational efficiencies, product mix, and benefit from domestic scale. Improved EBITDA per watt was attributed to streamlined consumption and better cell efficiencies, not higher realizations.
• Cell sales are priced in dollars, which management confirmed largely offsets input cost fluctuations from currency movements, providing a natural hedge.

DCR Mix Exceeds 50%; Non-DCR Off-Take Sees Temporary Delays

• DCR modules contributed ~50% of revenue mix in Q1 FY26-27, contributing to healthier margins. Blended module realization increased by ~Rs.1 due to the higher DCR sales, while non-DCR realization was 15-16 cents.
• Management expects the mix to shift more toward non-DCR modules in coming quarters due to module-to-cell capacity differences, but comfortable DCR inventories will be used to maintain DCR sales.
• C&I order inflows have begun in Q1 FY 2026-2027, with supply expected later in the fiscal year, signaling diversification beyond utility-scale and government-backed projects.
• Finished goods inventory rose by Rs.74.25 Cr due to elevated production levels, attributed to slower off-take in the non-DCR segment. Management described the off-take delay as temporary, caused by LC establishment and other procedural issues, with movement expected in the current month.
• The government imposed procedural restrictions on silver imports; management applied to DGST&D three months in advance and received approvals within 3-4 days, with no material impact on procurement or pricing. Silver pricing remains aligned with global import parity.
• ALMM List 2 (June 2026) is viewed as a milestone strengthening domestic manufacturing. Management noted tight domestic TOPCon cell supply should support pricing for compliant manufacturers.

Cell Utilization Peaks; Module Utilization Gradually Improving

• Cell capacity utilization improved sharply to 83% in Q1 FY26-27 (from 50% in Q4 FY25-26), with peak utilization capability of 85-90% already achieved during the quarter.
• Module production hit a record 970 MW in Q1 FY26-27 (+53% YoY), though peak module utilization is notionally 65%. Management expects production volumes to increase gradually and utilization to remain at similar levels in the coming quarters.
• Transition to G12R cell technology is partially completed, boosting effective capacity; the remaining conversion will be done sequentially.
• Raw material cost consumed dropped 18-19% QoQ despite higher production, driven by a richer DCR module mix and inclusion of merchant cell sales. Management cautioned this trend depends on ongoing product mix.
• Merchant cell sales increased meaningfully QoQ, described as the highest in company history, though not yet a dominant portion of the mix.